Trial Profile
A phase Ia trial of APD-811
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Jun 2017
Price :
$35
*
At a glance
- Drugs Ralinepag (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions
- Sponsors Arena Pharmaceuticals
- 01 Jun 2017 New trial record
- 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society
- 16 May 2017 According to an Arena Pharmaceuticals media release, data from this trial will be presented at the American Thoracic Society (ATS) 2017 International Conference.